Potassium Transporting Atpase Subunit Beta

Introduction

The potassium transporting ATPase subunit beta is an essential component of various ion pumps crucial for maintaining cellular homeostasis. These proteins are fundamental to diverse physiological processes, including nerve impulse transmission, muscle contraction, and fluid balance. As a regulatory subunit, it works in concert with a catalytic alpha subunit to ensure proper function and localization of the enzyme complex at the cell membrane.

Biological Basis

The potassium transporting ATPase subunit beta is a type II transmembrane glycoprotein that plays a vital role in the assembly, stability, and trafficking of the catalytic alpha subunit of P-type ATPases, such as the sodium-potassium ATPase (Na+/K+-ATPase) and hydrogen-potassium ATPase (H+/K+-ATPase). While the alpha subunit contains the ion-binding and ATP-hydrolysis sites, the beta subunit is critical for the correct folding and maturation of the alpha subunit in the endoplasmic reticulum, facilitating its transport to the plasma membrane. It also influences the enzyme’s potassium affinity and overall activity, ensuring efficient ion transport across cell membranes. Genes encoding these beta subunits are part of the_ATP1B_ family.

Clinical Relevance

Dysfunction of potassium transporting ATPases, and by extension their beta subunits, can have significant health implications due to their broad roles in cellular function. Imbalances in ion gradients maintained by these pumps can contribute to conditions affecting the cardiovascular system, kidneys, and nervous system. For instance, specific genetic variations in the genes encoding these subunits have been investigated for their association with various health traits. The single nucleotide polymorphism (SNP)*rs10483844 *has been associated with cardiovascular indicators such as Stage 2 Exercise heart rate, Baseline brachial artery flow velocity, and brachial artery flow-mediated dilation percent.^[1]These associations highlight the role of these proteins in regulating vascular function and the heart’s response to physical activity.

Social Importance

Given its fundamental role in cellular physiology, research into the potassium transporting ATPase subunit beta has significant social importance. Understanding the genetic and molecular basis of its function and dysfunction can lead to improved diagnostic tools and therapeutic strategies for a range of common diseases, including hypertension, heart failure, and metabolic disorders. By influencing crucial processes like blood pressure regulation and endothelial function, this protein directly impacts public health and the quality of life for millions globally. Continued study of its genetic variations, like*rs10483844 *, can further elucidate individual predispositions to cardiovascular conditions and inform personalized medicine approaches.

Limitations

Methodological and Statistical Constraints

The studies contributing to the understanding of genetic associations, including potentially for potassium transporting atpase subunit beta, faced several methodological and statistical limitations. The moderate size of the community-based cohorts, such as those in the Framingham Heart Study, resulted in limited statistical power to detect modest genetic effects, increasing the susceptibility to false negative findings.^[2] Conversely, the extensive multiple statistical testing inherent in genome-wide association studies (GWAS) raises the likelihood of false positive findings, making external replication in other cohorts essential for validating associations. ^[3] Many of the associations reported in these studies had not yet been replicated, implying that a considerable number of reported p-values might represent spurious discoveries.

Furthermore, the initial GWAS analyses often utilized 100K SNP arrays, which provided only partial coverage of the entire genetic variation within the genome. This limited coverage meant that some genes or genetic variants genuinely associated with phenotypes could be missed due to a lack of representation on the chip, thus preventing a comprehensive assessment of candidate genes. ^[4] The choice of analytical models, such as focusing solely on sex-pooled analyses, may have also obscured sex-specific genetic associations that could influence gene function, further limiting the depth of genetic discovery. ^[4]

Phenotype Definition and Measurement Variability

Challenges in phenotype definition and measurement also impact the interpretation of genetic findings. Several traits were assessed using indirect markers, such as cystatin C for kidney function or TSH for thyroid function, without comprehensive measures like free thyroxine.^[3]This reliance on surrogate markers introduces potential confounding, as these markers might reflect broader physiological states or cardiovascular disease risk beyond the primary trait of interest.^[3] Moreover, the equations used to estimate kidney function, like GFR, were often developed in smaller, selected samples or using different methodologies, casting uncertainty on their appropriateness for a large, population-based cohort. ^[3]

The longitudinal nature of data collection, with echocardiographic traits, for instance, averaged across examinations spanning up to two decades, presented additional complexities. ^[1] This long temporal window and the use of different equipment across examinations could introduce misclassification and dilute associations. ^[1] Such averaging also implicitly assumes that similar sets of genes and environmental factors influence traits uniformly across a wide age range, an assumption that might mask age-dependent genetic effects. ^[1] Additionally, many biomarker phenotypes exhibited non-normal distributions, necessitating complex statistical transformations that could affect the precision and generalizability of observed associations. ^[5]

Generalizability and Unaddressed Environmental Factors

A significant limitation of these studies is their generalizability, as the cohorts primarily consisted of individuals of white European descent. ^[3] This lack of ethnic diversity means that the applicability of the findings to other ethnic groups or more diverse populations remains uncertain, potentially limiting the clinical utility and broader scientific relevance of the discoveries. ^[3] Genetic variants can have context-specific effects, with their influence modulated by environmental factors, yet these studies generally did not undertake investigations of gene-environmental interactions. ^[1]

The absence of detailed analyses into gene-environment interactions overlooks crucial modifiers of genetic associations, such as the reported variation in the effects of ACE and AGTR2 on LV mass based on dietary salt intake. ^[1] This omission restricts a comprehensive understanding of how genes, including potassium transporting atpase subunit beta, interact with lifestyle and environmental exposures to influence complex traits. Consequently, the observed genetic associations might only explain a fraction of the phenotypic variation, highlighting remaining knowledge gaps in the complex interplay of genetics and environment in disease etiology.

Variants

The _IGHV3-73_ gene, or Immunoglobulin Heavy Variable 3-73, is a critical component of the human immune system, specifically involved in generating the diverse repertoire of antibodies that protect the body from pathogens. As a member of the immunoglobulin heavy chain variable region gene family, _IGHV3-73_ contributes to the antigen-binding site of antibodies, determining their specificity and affinity for foreign substances . This gene’s role is central to adaptive immunity, enabling the body to recognize and neutralize a vast array of threats, from viruses and bacteria to toxins. Variations within such genes can significantly influence an individual’s immune responsiveness and susceptibility to various diseases.

The single nucleotide polymorphism (SNP)*rs2073668 * is located within or near the _IGHV3-73_ gene, potentially influencing its expression, mRNA stability, or the structure of the resulting antibody protein . Such genetic variations can alter the efficiency with which B cells produce antibodies or modify the binding characteristics of these antibodies to antigens. Consequently, *rs2073668 * may contribute to differences in immune responses, including antibody production levels, antigen recognition profiles, and overall immune system regulation. These alterations can have widespread effects on health, ranging from vaccine effectiveness to susceptibility to autoimmune conditions.

The implications of *rs2073668 * and _IGHV3-73_extend to physiological processes like the function of potassium transporting ATPase subunit beta. Potassium-transporting ATPases, such as the sodium-potassium pump, are vital for maintaining cellular ion gradients, which are fundamental to nerve impulse transmission, muscle contraction, and cellular volume regulation . Subunit beta of these ATPases, represented by genes likeATP1B1, ATP1B2, or ATP1B3, plays a crucial role in enzyme trafficking, stability, and catalytic activity. Immune system dysregulation, potentially influenced by variants like *rs2073668 * in _IGHV3-73_, can indirectly impact these ion pumps through inflammatory mediators or autoantibodies targeting ion channels or their regulatory components. This connection highlights a complex interplay between the adaptive immune system and fundamental cellular homeostatic mechanisms.

Key Variants

RS ID	Gene	Related Traits
rs2073668	IGHV3-73	potassium-transporting ATPase subunit beta measurement protein measurement

Biological Background

Molecular Function and Cellular Ion Homeostasis

The potassium transporting ATPase subunit beta is a vital component of enzymatic complexes that meticulously regulate the movement of potassium ions across cell membranes. These ATPase enzymes are crucial for establishing and maintaining the electrochemical gradients of potassium, which are fundamental for a wide array of cellular functions, including nutrient uptake, the precise regulation of cell volume, and the generation of electrical signals essential for excitable cells.^[6]By hydrolyzing ATP, these ATPases actively transport potassium ions against their concentration gradients, often in coordinated exchange with other ions like sodium, to preserve the cell’s delicate ionic balance. The beta subunit specifically plays a role in the structural integrity of the pump and often influences its enzymatic activity and proper localization within the cell membrane.

The critical role of potassium ion transport is highlighted by its interconnection with other cellular systems, such as the ATP-sensitive potassium channels. These channels directly link the cell’s metabolic state, particularly its ATP levels, to its electrical excitability, allowing for dynamic adjustments in membrane potential.^[6]This metabolic coupling of ion channels and active transporters ensures that cells can rapidly respond to changes in energy availability, making precise control over potassium flux indispensable for maintaining cellular homeostasis and the proper functioning of specialized tissues throughout the body.

Genetic Influence on Cardiac and Vascular Physiology

Genetic variations within or near the genes encoding components of ion transport systems, including the region responsible for ATP-sensitive potassium channels, exert profound effects on cardiovascular health and function. For instance, studies have identified specific haplotype structures and genotype-phenotype correlations within the ATP-sensitive potassium channel gene region that are relevant to conditions like type 2 diabetes, which frequently involves significant cardiovascular complications.^[6]Such genetic polymorphisms can alter the expression levels, functional activity, or membrane trafficking of these essential transport proteins, thereby influencing cellular potassium dynamics and overall physiological responses.

Beyond the direct ion transport machinery, a network of other genes and signaling pathways also intricately regulates cardiac and vascular physiology. The PRKAG2 gene, which encodes a gamma2 subunit of 5’-AMP-activated protein kinase and is highly expressed in the heart, is crucial for cellular energy sensing and metabolism, with genetic mutations linked to various cardiac dysfunctions. ^[7] Similarly, transcription factors such as MEF2Care indispensable for proper cardiac morphogenesis and myogenesis during development, and their aberrant regulation can precipitate severe heart conditions like dilated cardiomyopathy.^[8] These interconnected genetic and molecular pathways underscore the complex regulatory landscape governing heart and vascular health, where ion transport, energy metabolism, and developmental processes converge.

Systemic Consequences and Pathophysiological Processes

Dysregulation of potassium transport and related ion handling mechanisms can lead to a spectrum of pathophysiological conditions, with particularly significant impacts on the cardiovascular system. Hypertension, for example, is a complex disorder that can arise from impaired regulation of vascular tone and disruptions in electrolyte balance, where genetic predispositions often exhibit context-dependent effects.^[9]Angiotensin II, a powerful vasoconstrictor, contributes to this by increasing phosphodiesterase 5A expression in vascular smooth muscle cells, which in turn antagonizes the beneficial effects of cGMP signaling, thereby promoting vasoconstriction and elevated blood pressure.^[10] This interaction illustrates how hormonal signals directly influence cellular processes to modulate systemic hemodynamics.

Severe cardiac pathologies, including dilated cardiomyopathy and familial Wolff-Parkinson-White syndrome, are also associated with critical disruptions in ion channels and transport mechanisms.^[11] Furthermore, inherited channelopathies affecting the cardiac ryanodine receptor (hRyR2), a calcium release channel essential for muscle contraction, can precipitate life-threatening arrhythmias such as catecholaminergic polymorphic ventricular tachycardia.^[12] These examples highlight the absolute necessity of precise and tightly regulated ion fluxes for maintaining normal heart rhythm and overall physiological stability, as even minor imbalances can lead to profound systemic dysregulation.

Interplay with Metabolic Regulation

The functionality of potassium transporting ATPases and associated ion channels is intimately linked with metabolic regulatory processes, playing a direct role in critical functions like glucose homeostasis. The ATP-sensitive potassium channels, in particular, are pivotal mediators in glucose-stimulated insulin secretion from pancreatic beta cells, providing a direct molecular connection between the cell’s metabolic energy status (ATP levels) and its capacity to release insulin.^[6]Consequently, any dysfunction in these channels can impair appropriate insulin responses, contributing significantly to the pathogenesis of type 2 diabetes.

Beyond these direct mechanistic links, broader metabolic health is closely correlated with cardiovascular outcomes. Research indicates a clear association between elevated serum urate levels and the prevalence of conditions such as hypertension and other cardiovascular diseases, underscoring the complex, multi-systemic nature of metabolic interconnections.^[13] While the SLC2A9gene encodes a glucose transporter predominantly expressed in the kidney and liver, andSLC22A12functions as a renal urate anion exchanger, these represent distinct transport proteins that collectively contribute to maintaining systemic metabolic balance, with both direct and indirect implications for cardiovascular and renal health.^[14]

Pathways and Mechanisms

Fundamental Ion Transport and Energy Coupling

The potassium transporting atpase subunit betaplays a crucial role in maintaining cellular potassium homeostasis and membrane potential by facilitating the active transport of ions across biological membranes. This process is inherently energy-intensive, directly coupling ion movement to ATP hydrolysis. The continuous operation of such ATPases is fundamental for numerous cellular functions, including nerve impulse propagation, muscle contraction, and maintaining cell volume. Cellular energy status, particularly the balance between ATP and AMP, is a critical regulator of energy-consuming processes. For instance, the 5’-AMP-activated protein kinase (PRKAG2), a metabolic sensor, can respond to changes in cellular energy levels, potentially influencing the activity or expression of ATP-dependent transporters to match energy demand with supply.^[7] Abnormalities in energy metabolism, such as those seen in erythrocyte enzyme defects leading to glycolysis disruptions, underscore the essential link between cellular energy generation and the maintenance of vital cellular functions, including ion transport. ^[15]

Cellular Signaling and Transcriptional Regulation

The activity and expression of potassium-transporting ATPases are tightly controlled by various intracellular and extracellular signaling pathways, ensuring dynamic adaptation to physiological needs. Receptor activation often initiates signaling cascades that modulate gene expression, leading to altered synthesis of ATPase subunits. For example, the mitogen-activated protein kinase (MAPK) pathway is a key signaling cascade responsive to various stimuli, and its activation patterns are influenced by factors such as age and acute exercise in human skeletal muscle, indicating a broad role in cellular adaptation.^[16] Furthermore, specific transcription factors, such as Myocyte Enhancer Factors 2A and 2C (MEF2A, MEF2C), are critical regulators of gene expression in cardiac development and can induce pathological conditions like dilated cardiomyopathy when dysregulated, illustrating how transcriptional control directly impacts protein levels and cellular function.^[8]The regulation of gene expression by signaling molecules, as seen with Angiotensin II increasing phosphodiesterase 5A expression in vascular smooth muscle cells to antagonize cGMP signaling, demonstrates a complex interplay between external signals and the transcriptional machinery controlling cellular responses.^[10]

Post-Translational Control and Protein Dynamics

Beyond transcriptional regulation, the function of the potassium transporting atpase subunit beta can be finely tuned through various post-translational modifications and protein-protein interactions. These mechanisms can impact protein stability, localization, and intrinsic enzymatic activity without altering protein synthesis. For example, ubiquitin ligases, such as the RING-H2 finger ubiquitin ligase PJA1, play a critical role in targeting proteins for degradation, a process that can regulate the steady-state levels of transporters and other cellular proteins. ^[17]Additionally, alternative splicing, a post-transcriptional regulatory mechanism, generates different protein isoforms from a single gene, thereby diversifying protein function and responsiveness. This process is recognized for its multiple control mechanisms and involvement in human disease, highlighting its significance in shaping the proteome and influencing protein activity.^[18]The interaction of proteins, such as those interacting with the thyroid hormone receptor in a hormone-dependent manner, also exemplifies how molecular binding events can allosterically modulate protein function and participate in regulatory networks.^[19]

Integrated Physiological Networks

The function of potassium transporting atpase subunit betadoes not operate in isolation but is intricately integrated within broader physiological networks, demonstrating significant pathway crosstalk and network interactions. Maintaining precise potassium gradients is crucial for the function of other transporters and channels, impacting various systemic processes. For instance, theSLC2A9 gene (GLUT9) encodes a facilitative glucose transporter family member that also functions as a renal urate anion exchanger, critically influencing serum uric acid levels and excretion.^[20]This exemplifies how different transport systems are interlinked in maintaining systemic metabolic homeostasis. Furthermore, the disruption of other ion channels, such as the CFTR chloride channel, can alter the mechanical properties and ion transport capabilities of cells like mouse aortic smooth muscle cells, indicating a complex interdependence among various ion transport systems that collectively contribute to tissue function^[21] Such hierarchical regulation and network interactions give rise to emergent properties at the cellular and organ level, where the coordinated action of multiple components dictates overall physiological output.

Clinical Relevance and Disease Mechanisms

Dysregulation of potassium transporting ATPases and associated pathways can have profound clinical implications, contributing to the pathophysiology of various diseases and offering potential therapeutic targets. Perturbations in ion transport mechanisms are often central to disease development. For example, the islet ATP-sensitive potassium channel gene region is implicated in type 2 diabetes, underscoring the critical role of potassium channels in pancreatic beta-cell function and glucose homeostasis.^[6] Similarly, mutations in other crucial ion channels, such as the cardiac ryanodine receptor gene (hRyR2), are directly linked to catecholaminergic polymorphic ventricular tachycardia, demonstrating how defects in ion channel function can lead to severe cardiac arrhythmias. ^[22]Understanding these disease-relevant mechanisms, including pathway dysregulation and compensatory responses, is vital for identifying novel therapeutic strategies. The use of metabolomics, for example, serves as a platform for studying drug toxicity and gene function, offering insights into metabolic phenotypes and potential therapeutic interventions.^[23]

Clinical Relevance

Cardiovascular Risk and Endothelial Function

Variations within the potassium transporting atpase subunit beta gene, such as the rs10483844 variant, have been associated with key indicators of brachial artery endothelial function, including Baseline BA flow velocity and BA FMD percent. ^[1]Endothelial dysfunction, characterized by altered brachial artery flow velocity and reduced flow-mediated dilation (FMD), is an early marker of atherosclerosis and a strong predictor of future cardiovascular events. Understanding the genetic determinants of these traits can enhance diagnostic utility by identifying individuals at higher risk for cardiovascular diseases even before clinical symptoms appear.

The association of potassium transporting atpase subunit betawith brachial artery function traits provides a basis for improved cardiovascular risk assessment and identification of related conditions.^[1] By evaluating an individual’s genetic profile, particularly concerning the rs10483844 variant, clinicians may gain insights into their predisposition to impaired endothelial health. This allows for earlier intervention strategies, potentially mitigating the progression to more severe cardiovascular complications and overlapping phenotypes related to vascular dysfunction.

Exercise Response and Prognostic Value

The potassium transporting atpase subunit beta gene, specifically through the rs10483844 variant, has also been linked to Stage 2 Exercise heart rate.^[1]Exercise heart rate response is a crucial physiological parameter reflecting cardiovascular fitness and the heart’s ability to adapt to physical stress. A suboptimal or exaggerated heart rate response during exercise can serve as an independent prognostic indicator for various cardiac outcomes, including risk of mortality and the development of heart failure.

Therefore, genetic variations in potassium transporting atpase subunit betamay hold prognostic value by influencing an individual’s exercise heart rate.^[1]This genetic insight could contribute to predicting long-term cardiovascular outcomes and disease progression, as well as an individual’s potential response to exercise-based therapies. Such information supports the development of personalized monitoring strategies, allowing healthcare providers to tailor follow-up and interventions based on a patient’s genetic predisposition to exercise heart rate abnormalities.

Personalized Approaches in Cardiovascular Management

The associations of potassium transporting atpase subunit beta variants, such as rs10483844 , with both brachial artery endothelial function and exercise heart rate responses, underscore its potential role in personalized medicine approaches.^[1]Integrating genetic information with clinical assessments can facilitate more precise risk stratification for cardiovascular disease. By identifying individuals who may be at an elevated risk due to specific genetic predispositions, targeted preventive strategies can be implemented, moving beyond general population recommendations.

Such personalized approaches enable the development of tailored prevention strategies and individualized management plans. For instance, individuals with specific variants in potassium transporting atpase subunit betacould benefit from more intensive lifestyle interventions, closer monitoring, or earlier initiation of pharmacotherapy to manage their cardiovascular risk.^[1]This precision medicine paradigm aims to optimize patient care by matching interventions to an individual’s unique genetic profile, thereby potentially improving outcomes and enhancing overall cardiovascular health.

References

[1] Vasan, Ramachandran S. “Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study.”BMC Medical Genetics, vol. 8, no. 1, 2007, p. 54.

[2] Benjamin, Emelia J., et al. “Genome-wide association with select biomarker traits in the Framingham Heart Study.” BMC Medical Genetics, vol. 8, no. 1, 2007.

[3] Hwang, Shih-Jen, et al. “A genome-wide association for kidney function and endocrine-related traits in the NHLBI’s Framingham Heart Study.” BMC Medical Genetics, vol. 8, no. 1, 2007.

[4] Yang, Qiong, et al. “Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study.”BMC Medical Genetics, vol. 8, no. 1, 2007.

[5] Melzer, David, et al. “A genome-wide association study identifies protein quantitative trait loci (pQTLs).” PLoS Genetics, vol. 4, no. 5, 2008.

[6] Florez JC, Burtt N, de Bakker PIW, Almgren P, Tuomi T, Holmkvist J, Gaudet D, Hudson TJ, Schaffner SF, Daly MJ, Hirschhorn JN, Groop L, Altshuler D. “Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region.”Diabetes, 2004, 53(5):1360-1368.

[7] Lang T, Yu L, Tu Q, Jiang J, Chen Z, Xin Y, Liu G, Zhao S. “Molecular cloning, genomic organization, and mapping of PRKAG2, a heart abundant gamma2 subunit of 5’-AMP-activated protein kinase, to human chromosome 7q36.” Genomics, 2000, 70:258-263.

[8] Lin Q, Schwarz J, Bucana C, Olson EN. “Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C.” Science, 1997, 276:1404-1407.

[9] Kardia SL. “Context-dependent genetic effects in hypertension.”Curr Hypertens Rep, 2000, 2:32-38.

[10] Kim D, Aizawa T, Wei H, Pi X, Rybalkin SD, Berk BC, Yan C. “Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: a mechanism by which angiotensin II antagonizes cGMP signaling.”J Mol Cell Cardiol, 2005, 38:175-184.

[11] Gollob MH, Green MS, Tang AS, Gollob T, Karibe A, li Hassan AS, Ahmad F, Lozado R, Shah G, Fananapazir L, Bachinski LL, Roberts R. “Identification of a gene responsible for familial Wolff-Parkinson-White syndrome.” N Engl J Med, 2001, 344:1823-1831.

[12] Benkusky NA, Farrell EF, Valdivia HH. “Ryanodine receptor channelopathies.” Biochem Biophys Res Commun, 2004, 322:1280-1285.

[13] Wallace C. “Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia.”Am J Hum Genet, 2008, 82(1):139-49.

[14] Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, et al. “Molecular identification of a renal urate anion exchanger that regulates blood urate levels.”Nature, 2002, 417:447–452.

[15] van Wijk, R., and W.W. van Solinge. “The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis.” Blood, vol. 106, 2005, pp. 4034–4042.

[16] Williamson, D., et al. “Mitogen-activated protein kinase (MAPK) pathway activation: effects of age and acute exercise on human skeletal muscle.”J Physiol, vol. 547, 2003, pp. 977–987.

[17] Yu, P., et al. “PJA1, encoding a RING-H2 finger ubiquitin ligase, is a novel human X chromosome gene abundantly expressed in brain.” Genomics, vol. 79, 2002, pp. 869–874.

[18] Caceres, J.F., and A.R. Kornblihtt. “Alternative splicing: multiple control mechanisms and involvement in human disease.”Trends Genet, vol. 18, 2002, pp. 186–193.

[19] Lee, J.W., et al. “Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor.”Mol. Endocrinol., vol. 9, 1995, pp. 243–254.

[20] Li, S., et al. “The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts.”PLoS Genet, vol. 3, no. 11, 2007, p. e147.

[21] Robert, R., et al. “Disruption of CFTR chloride channel alters mechanical properties and cAMP-dependent Cl-transport of mouse aortic smooth muscle cells.”J Physiol (Lond), vol. 568, 2005, pp. 483–495.

[22] Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, Sorrentino V, Danieli GA. “Mutations in the Cardiac Ryanodine Receptor Gene (hRyR2) Underlie Catecholaminergic PolyVentricular Tachycardia.” Circulation, 2001, 103:196-200.

[23] Nicholson, J.K., et al. “Metabonomics: a platform for studying drug toxicity and gene function.” Nat Rev Drug Discov, vol. 1, 2002, pp. 153–161.